Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
- MIS Systems
- Online Data Verification
Support
- Facilitation Desk
- Complaints

Home > Safety Info > Product Recalls > Recall Alerts > Drug Product Recall; Flagynase Suspension (Batch # 0244) by M/s. Aries Pharmaceuticals Pvt. Ltd, Peshawar.

Drug Product Recall; Flagynase Suspension (Batch # 0244) by M/s. Aries Pharmaceuticals Pvt. Ltd, Peshawar.

Ijaz Mustafa Recall Alerts April 8, 2022April 8, 2022

Flagynase-suspension-Recall-Alert-11 Download

Share this:

Twitter
Facebook

← DRAP issues guidelines on Good Pharmacovigilance Practices for Product Registration Holders
DRAP seeks comments of stakeholders on draft guidance document for Clinical Trials Applicants →

Product Recalls
Safety Communication
Safety Reporting
Report a Problem

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem